Goldman Sachs Group Inc Repare Therapeutics Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 110,906 shares of RPTX stock, worth $146,395. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110,906
Holding current value
$146,395
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$1.25 - $3.97 $138,632 - $440,296
110,906 New
110,906 $145,000
Q2 2024

Aug 13, 2024
SELL
$3.02 - $4.7 $48,676 - $75,754
-16,118 Reduced 44.42%
20,169 $66,000
Q1 2024

May 15, 2024
BUY
$4.53 - $8.41 $33,290 - $61,805
7,349 Added 25.4%
36,287 $170,000
Q4 2023

Feb 13, 2024
SELL
$3.22 - $11.79 $114,016 - $417,472
-35,409 Reduced 55.03%
28,938 $211,000
Q3 2023

May 14, 2024
BUY
$8.16 - $13.01 $288,937 - $460,671
35,409 Added 122.36%
64,347 $777,000
Q3 2023

Nov 14, 2023
SELL
$8.16 - $13.01 $5,475 - $8,729
-671 Reduced 1.03%
64,347 $777,000
Q2 2023

May 14, 2024
SELL
$8.63 - $12.53 $103,499 - $150,272
-11,993 Reduced 15.57%
65,018 $687,000
Q2 2023

Aug 14, 2023
SELL
$8.63 - $12.53 $103,499 - $150,272
-11,993 Reduced 15.57%
65,018 $687,000
Q1 2023

May 14, 2024
BUY
$9.32 - $15.06 $117,124 - $189,259
12,567 Added 19.5%
77,011 $757,000
Q1 2023

May 11, 2023
BUY
$9.32 - $15.06 $117,124 - $189,259
12,567 Added 19.5%
77,011 $757,000
Q4 2022

May 14, 2024
BUY
$12.5 - $18.13 $189,175 - $274,379
15,134 Added 30.69%
64,444 $947,000
Q4 2022

Feb 13, 2023
BUY
$12.5 - $18.13 $189,175 - $274,379
15,134 Added 30.69%
64,444 $947,000
Q3 2022

May 14, 2024
SELL
$11.57 - $15.59 $8,851 - $11,926
-765 Reduced 1.53%
49,310 $598,000
Q3 2022

Nov 10, 2022
SELL
$11.57 - $15.59 $8,851 - $11,926
-765 Reduced 1.53%
49,310 $598,000
Q2 2022

May 14, 2024
BUY
$8.45 - $14.84 $178,607 - $313,673
21,137 Added 73.04%
50,075 $700,000
Q2 2022

Aug 15, 2022
BUY
$8.45 - $14.84 $70,388 - $123,617
8,330 Added 19.95%
50,075 $700,000
Q1 2022

May 16, 2022
BUY
$11.38 - $21.88 $121,185 - $233,000
10,649 Added 34.25%
41,745 $594,000
Q4 2021

Feb 14, 2022
SELL
$19.66 - $28.11 $178,139 - $254,704
-9,061 Reduced 22.56%
31,096 $656,000
Q3 2021

Nov 10, 2021
BUY
$25.71 - $35.24 $1.03 Million - $1.42 Million
40,157 New
40,157 $1.05 Million

Others Institutions Holding RPTX

# of Institutions
59
Shares Held
33.6M
Call Options Held
51K
Put Options Held
0
View Full List

About Repare Therapeutics Inc.

RPTX Quotes by TradingView
  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $55.4M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email